- Exhibits its latest advancements for pathologists and clinicians
- Brings together industry experts for knowledge sharing sessions
At the recently concluded MAPCON, Transasia offered the attending pathologists an opportunity to gain insights into the latest advancements in the in-vitro diagnostic industry. In its 39th year, the Annual Conference of the Maharashtra Chapter of IAPM (MAPCON) was held between 7th and 9th September, 2018 and hosted by the Armed Forces Medical College (AFMC), Pune.
As the principal partner, Transasia organized two scientific sessions: ‘Acquired bleeding disorders’ by Dr. (Col.) Jyoti Kotwal, Sr. Consultant, Dept. of Hematology, SGRH & GRIPMER, New Delhi and ‘Pathophysiology and diagnosis of Hemophilia’ by Dr. Swati Pai, Head of Dept.- Lab Medicine, Manipal Hospitals, Bengaluru.
At its booth, Transasia commemorated the trust, commitment and service of our armed forces. It further harnessed its position as a leader in the Indian IVD Industry by showcasing its latest and best technologies. ‘Make in India’, fully automated biochemistry analyzers, XL-1000 and EM 200 and coagulation analyzer ECL 760 were on display. Additionally, Hb-Vario, its HPLC system and urine chemistry systems, Laura XL and Laura Smart were also exhibited alongwith the automated ESR system, Vesmatic Easy. Transasia is the sole distributor in India of the world-class Sysmex hematology analyzers, of which the 3 PDA, XP-100 and 6 PDA, XN 330 were showcased.
Further, Transasia’s rapid diagnostic kits, that offer unmatched sensitivity and specificity for dengue and malaria detection were well received at the booth.
Besides quality products and solutions, Transasia also provides a sophisticated LIMS, through its information technology partner, CAREDATA. At the booth, the CAREDATA team offered the visiting delegates solutions for enhanced lab efficiency.
About Transasia Bio-Medicals Ltd.:
Founded in 1979, Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company offers products and solutions in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Diabetes Management, Microbiology and Molecular Diagnostics.
Transasia provides doctors and patients with reliable, affordable and innovative Medical Diagnostic Systems, with an impressive install base of above 65,000 equipment across India. It has a vast network of the more than 300+ service and application support specialists, 400+ sales and marketing team, 24 zonal offices and 350+ distributors.
It is the first Indian company to manufacture and export blood analyzers and reagents, in the 1990s. Today, Transasia’s indigenous research has resulted in development of state of the art, ‘Make in India’ products and technologies, enabling its products to be among the best in the world.
All along its journey spanning more than three decades, Transasia has been recognized for its commitment to healthcare. The Govt. of India recently bestowed Transasia with ‘The India Medical Devices Export Company of the Year’ award amongst many others. Besides this, Transasia was conferred the Best Medical Equipment Company of the Year-2017’ by Medgate Today and the ‘Economic Times- Best Healthcare Brand 2016’ amongst many others.
Headquartered in Mumbai, Transasia is a part of the global Erba Diagnostics Mannheim GmbH Group. The Erba –Transasia Group has spread its footprint across USA, UK, Germany, Czech Republic, France, Italy, Russia and Turkey through various acquisitions.
Erba’s production sites in India, Czech Republic and USA and R&D centres in France, UK, India and Czech Republic form a hub for indigenous manufacturing of world class deliverables.Today, the Erba -Transasia Group serves millions across 100 countries. For further information, kindly visit www.erbamannheim.com